What Is Synthetic Biology?

Table of Contents

Synthetic biology is the application of engineering principles to biology — designing, constructing, and testing biological systems and organisms that perform new functions not found in nature, or redesigning existing biological systems to work more efficiently.

Think of it this way: traditional biology studies life as it exists. Genetic engineering modifies life by moving genes around. Synthetic biology goes a step further — it treats biological components like Lego bricks that can be designed, standardized, and assembled into systems that do whatever you want. Read DNA. Write DNA. Debug DNA. It’s biology meets software engineering, and it’s changing what’s possible.

Where This Came From

The intellectual roots of synthetic biology go back decades, but the field as we know it crystallized in the early 2000s. Three developments made it possible.

First, the Human Genome Project (completed in 2003) proved that entire genomes could be read — sequenced — at scale. The cost of DNA sequencing has dropped faster than any technology in history, including computing. Sequencing a human genome cost about $3 billion in 2001. Today it costs under $200. That’s a 15-million-fold cost reduction in about 20 years.

Second, DNA synthesis — writing new DNA sequences from scratch — became practical and affordable. Instead of cutting and pasting existing genes, scientists could design a DNA sequence on a computer and have it manufactured by a DNA synthesis company, delivered in the mail a few days later. The cost of synthesizing DNA has dropped from about $10 per base pair in the early 2000s to under $0.10 today.

Third, the rise of computational tools for biological design gave scientists the ability to model, simulate, and predict how engineered biological systems would behave — at least approximately. Without computational design, synthetic biology would be pure trial and error.

The term “synthetic biology” gained traction around 2004, when MIT hosted the first international conference on the topic and launched the iGEM (international Genetically Engineered Machine) competition — an undergraduate contest where student teams build biological systems from standardized parts. iGEM has since grown into a global phenomenon with hundreds of teams competing annually, and many successful biotech companies have spun out of iGEM projects.

How Synthetic Biology Works

The Design-Build-Test-Learn Cycle

Synthetic biology borrows the engineering design cycle. You design a biological system on a computer. You build it by synthesizing DNA and assembling it in cells. You test whether it works as intended. You learn from the results and iterate. Repeat until it works.

This sounds straightforward, but biology is messy. Engineered systems in electronics and mechanics behave predictably because the components are well-characterized and interactions are understood. Biological components are far less predictable. A gene that works perfectly in one organism might fail completely in another. Proteins interact in ways that are difficult to anticipate. Evolution constantly introduces mutations that can break engineered functions.

Despite these challenges, the design-build-test-learn approach has dramatically accelerated biological engineering. What used to take years of PhD work can now sometimes be accomplished in weeks.

Standardized Biological Parts

One of synthetic biology’s big ideas is standardization. Just as electronic circuits are built from standardized components (resistors, capacitors, transistors), biological systems can be built from standardized genetic parts.

The Registry of Standard Biological Parts at MIT catalogs thousands of characterized DNA sequences — promoters (that control when genes turn on), ribosome binding sites (that control protein production rates), coding sequences (the genes themselves), and terminators (that signal where genes end). Each part has a standard interface, so parts can be combined in predictable ways.

In practice, standardization in biology is harder than in electronics. Biological parts don’t always behave the same way in different contexts — a phenomenon called “context dependence.” But the effort to standardize has still been enormously productive, enabling rapid prototyping and making biological engineering more accessible.

CRISPR and Gene Editing

CRISPR-Cas9, discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier (who won the Nobel Prize in Chemistry in 2020), gave synthetic biology a precision tool for editing DNA in living cells. CRISPR acts like molecular scissors — it can cut DNA at a specific location, allowing scientists to delete genes, insert new ones, or modify existing sequences with unprecedented ease.

Before CRISPR, editing a genome was expensive, slow, and technically demanding. CRISPR made it fast, cheap, and accessible to virtually any biology lab. It’s been described as the word processor of genetics — making edits that were once laborious into routine operations.

Newer CRISPR variants offer even more precision. Base editors can change individual DNA letters without cutting the double strand. Prime editors can insert, delete, or replace sequences with minimal collateral damage. These tools are making synthetic biology more precise and reliable with each generation.

Cell-Free Systems

Not all synthetic biology happens inside living cells. Cell-free systems use purified biological machinery — enzymes, ribosomes, nucleotides — in a test tube, without any living cell. You add DNA encoding your desired protein, and the cell-free system produces that protein in hours.

Cell-free systems are faster than cell-based approaches (no need to grow and maintain living cultures), safer (no self-replicating organisms), and more controllable. They’re particularly useful for rapid prototyping — testing many designs quickly before committing to the slower process of engineering living cells.

Applications include diagnostic tests (some COVID-19 tests used cell-free synthetic biology), on-demand production of vaccines and therapeutics, and biosensors for environmental monitoring.

What Synthetic Biology Can Do

Medicine

Medicine is where synthetic biology is already making its biggest impact.

Artemisinin production is the field’s landmark success story. Artemisinin, the most effective antimalarial drug, was traditionally extracted from sweet wormwood plants — an expensive, unreliable supply chain. In 2013, Jay Keasling’s lab at UC Berkeley engineered yeast to produce artemisinic acid, a precursor to artemisinin. Sanofi now manufactures it at industrial scale, helping stabilize the global supply of this life-saving drug.

mRNA vaccines — including the Pfizer-BioNTech and Moderna COVID-19 vaccines — use synthetic biology principles. Scientists designed and synthesized the mRNA sequence encoding the SARS-CoV-2 spike protein, packaged it in lipid nanoparticles, and delivered it into human cells to trigger an immune response. The speed was remarkable — Moderna designed its vaccine sequence in just two days after receiving the virus’s genetic sequence in January 2020.

CAR-T cell therapy engineers a patient’s own immune cells to recognize and attack cancer. T cells are extracted, genetically modified to express a chimeric antigen receptor (CAR) targeting cancer cells, expanded in the lab, and infused back into the patient. Several CAR-T therapies are FDA-approved for blood cancers, with response rates of 50-90% in patients who had exhausted other options.

Engineered probiotics are being developed to treat gut diseases, metabolic disorders, and even depression. Companies like Synlogic engineer bacteria to produce therapeutic molecules directly in the gut — turning the microbiome into a drug delivery system.

Agriculture

Synthetic biology is creating crop improvements beyond what traditional breeding or first-generation genetic engineering could achieve.

Nitrogen fixation — the process by which certain bacteria convert atmospheric nitrogen into plant-usable forms — is a major target. Currently, the Haber-Bosch process (which produces synthetic nitrogen fertilizer) consumes about 1-2% of global energy and is responsible for roughly 1.5% of global CO2 emissions. Engineering crops to fix their own nitrogen, or engineering soil bacteria to do it more efficiently, could dramatically reduce fertilizer dependence.

Disease resistance through engineered immune receptors could protect crops against devastating pathogens like wheat rust, citrus greening, and banana wilt — diseases that threaten global food supplies.

Photosynthesis enhancement aims to make crops more efficient at converting sunlight to biomass. Natural photosynthesis is only about 1-2% efficient. Even modest improvements could significantly boost crop yields.

Materials and Manufacturing

Living organisms can produce materials with properties that synthetic chemistry struggles to match.

Spider silk proteins, produced by engineered bacteria or yeast, create fibers that are stronger than steel by weight and more elastic than nylon. Companies like Bolt Threads and Spiber are commercializing these materials for textiles, medical sutures, and composite materials.

Bioplastics made from engineered microorganisms could replace petroleum-based plastics with biodegradable alternatives. PHA (polyhydroxyalkanoate), produced by engineered bacteria feeding on plant sugars or waste gases, is already used in some packaging and disposable items.

Living building materials incorporate engineered bacteria into construction materials. Researchers at the University of Colorado Boulder created “living concrete” — a building material made with photosynthetic cyanobacteria that can actually grow, heal cracks, and sequester carbon dioxide.

Energy and Environment

Biofuels from engineered microorganisms are being developed as alternatives to fossil fuels. Companies like LanzaTech engineer bacteria to convert industrial waste gases (including CO2) into ethanol and other fuels. Others are engineering algae to produce hydrocarbons directly.

Bioremediation — using engineered organisms to clean up pollution — is an active research area. Bacteria have been engineered to break down plastics, neutralize heavy metals, and degrade toxic chemicals in contaminated soil and water.

Carbon capture using engineered organisms could supplement mechanical carbon capture. Some researchers are engineering plants and algae to fix more CO2 than their natural counterparts, while others are creating synthetic metabolic pathways more efficient than natural photosynthesis.

Biosensors

Engineered cells can act as extremely sensitive, specific detectors. Synthetic biology has created biosensors for:

Medical diagnostics — detecting disease biomarkers in blood, urine, or saliva at low cost
Environmental monitoring — detecting pollutants like arsenic, lead, or pesticides in water
Food safety — identifying pathogens or toxins in food products
Landmine detection — engineered bacteria that glow in the presence of explosives (yes, really)

The Ethics and Risks

Synthetic biology raises serious questions that the field has, to its credit, engaged with more proactively than many technologies.

Biosecurity

The same tools that enable beneficial applications could, in theory, be used to create dangerous pathogens. As DNA synthesis becomes cheaper and easier, concerns about “dual-use” research grow. Several governance measures are in place:

DNA synthesis companies screen orders against databases of dangerous sequences
The U.S. government requires review of research involving potential pandemic pathogens
The iGEM competition includes mandatory safety reviews for all projects
International discussions on biosecurity governance are ongoing, though progress is slow

Ecological Risks

Releasing engineered organisms into the environment raises questions about unintended consequences. An engineered bacterium that works perfectly in the lab might behave unpredictably in a complex ecosystem with millions of interacting species.

To address this, synthetic biologists have developed several containment strategies:

Kill switches — genetic circuits that cause engineered organisms to self-destruct under certain conditions (like the absence of a synthetic amino acid only available in the lab).

Genetic firewalls — using non-standard genetic codes or synthetic amino acids that don’t exist in nature, making it impossible for engineered genes to transfer to wild organisms.

Auxotrophies — engineering organisms to require nutrients that don’t exist in the environment, so they can only survive in controlled settings.

Equity and Access

Who benefits from synthetic biology? If engineered crops, medicines, and materials are developed primarily by wealthy-country companies and protected by patents, the technology could widen global inequalities rather than narrowing them. The open-source biology movement — exemplified by projects like OpenMTA (Material Transfer Agreement) and the BioBricks Foundation — aims to keep synthetic biology tools and knowledge broadly accessible.

The “Playing God” Question

Engineering life raises deep philosophical questions. Is there something inherently wrong with designing organisms? Does synthetic biology cross a line that genetic modification only approached? These questions don’t have easy answers, but they deserve serious discussion — not dismissal.

Where Is This Heading?

The pace of progress in synthetic biology is accelerating. Several trends are worth watching.

Whole-genome engineering — designing and synthesizing entire genomes from scratch — is becoming feasible for increasingly complex organisms. The Synthetic Yeast Genome Project (Sc2.0) is building a completely synthetic version of the yeast genome. Future projects may design custom genomes for organisms optimized for specific industrial or medical applications.

AI and machine learning are transforming biological design. Deep learning models can predict protein structures (AlphaFold), design new proteins (ProteinMPNN), and optimize genetic circuits far faster than human intuition. The combination of AI and synthetic biology may be more powerful than either alone.

Biofoundries — automated facilities that can design, build, and test thousands of biological constructs simultaneously — are making synthetic biology faster and more systematic. These facilities use robotics, high-throughput screening, and data analysis to parallelize the design-build-test-learn cycle.

Xenobiology — creating life forms based on alternative biochemistries (different genetic codes, synthetic amino acids, or even different nucleotide base pairs) — pushes toward truly alien biology that has no precedent in natural evolution.

Synthetic biology is still young. The field’s most important applications probably haven’t been invented yet. But the trajectory is clear: biology is becoming an engineering discipline, and engineered biology will increasingly shape medicine, agriculture, manufacturing, and the environment. Whether that’s exciting or terrifying probably depends on how much you trust human judgment — which, historically, is a complicated bet.

Frequently Asked Questions

How is synthetic biology different from genetic engineering?

Traditional genetic engineering typically moves existing genes between organisms. Synthetic biology goes further — it designs entirely new genetic sequences, builds standardized biological parts, and engineers whole biological systems from scratch using engineering principles like modularity and standardization.

Is synthetic biology safe?

Synthetic biology carries risks like any powerful technology, including potential misuse and ecological concerns. The field has extensive biosafety and biosecurity frameworks. Engineered organisms are typically designed with built-in safety features like kill switches and genetic firewalls. Ongoing governance efforts involve scientists, ethicists, and policymakers.

What products are made using synthetic biology today?

Current commercial products include the antimalarial drug artemisinin (produced in engineered yeast), synthetic fragrances and flavors, bio-based materials like spider silk proteins, engineered probiotics, mRNA vaccines, and various industrial enzymes and chemicals.

Can synthetic biology create new life forms?

In 2010, Craig Venter's team created a bacterial cell controlled entirely by a chemically synthesized genome — the first organism with a fully synthetic DNA. However, it used an existing cell as a 'chassis.' Creating truly new life from non-living chemicals remains beyond current capabilities.